FormFactor, Inc. Reports 2018 First Quarter Results
May 02, 2018 20:06 pm UTC| Business
LIVERMORE, Calif., May 02, 2018 -- FormFactor, Inc. (Nasdaq:FORM) today announced its financial results for the first quarter of fiscal 2018 ended March 31, 2018. Quarterly revenues were $118.3 million, down 10.3% from...
Kimball Electronics, Inc. Reports Record Third Quarter Fiscal Year 2018 Results
May 02, 2018 20:06 pm UTC| Business
Net sales quarterly record of $284 million, a 22% increase from the prior year third quarterQuarterly records for Net Income of $10.8 million and Diluted EPS of $0.40, each up 33% year-over-year Cash flow from operating...
Peak Resorts Announces Strong Pre-Season 2018/19 Season Pass Sales
May 02, 2018 20:05 pm UTC| Business
WILDWOOD, Mo., May 02, 2018 -- Peak Resorts, Inc. (NASDAQ:SKIS) (“Peak” or the “Company”), a leading owner and operator of high-quality, individually branded U.S. ski resorts, announced today strong initial sales for...
OptimizeRx Announces $9 Million Private Placement
May 02, 2018 20:05 pm UTC| Business
ROCHESTER, Mich., May 02, 2018 -- OptimizeRx Corp. (OTCQB:OPRX), the nation’s leading provider of digital health messaging for the pharmaceutical industry, has entered into a definitive agreement with two institutional...
Fox Factory Holding Corp. Announces First Quarter 2018 Financial Results
May 02, 2018 20:05 pm UTC| Business
First Quarter 2018 Sales Increased 22.1% to a Record $129.8 Million; Exceeds Company GuidanceGross Margin Increased 40 Basis Points to 32.1%Achieves Earnings per Diluted Share of $0.55; Adjusted Earnings per Diluted Share...
Electromagnetics Software Release Targets e-Mobility and Communications Markets
May 02, 2018 20:05 pm UTC| Business
TROY, Mich., May 02, 2018 -- Altair (Nasdaq:ALTR) has released the 2018 versions of leading electromagnetic (EM) simulation software FEKO®, WinProp®, Flux® and FluxMotor®. These electromagnetic solver tools, part of...
Conatus Pharmaceuticals Reports First Quarter 2018 Financial Results and Program Updates
May 02, 2018 20:05 pm UTC| Business
SAN DIEGO, May 02, 2018 -- Conatus Pharmaceuticals Inc. (Nasdaq:CNAT), a biotechnology company focused on the development of novel medicines to treat liver disease, today announced financial results for the first...